|
Mar. 10, 2010: Drug Rediscovery Group Gets FDA Approval for Rare Disease Trials
Jan. 21, 2010: First U.S. Stem Cells Transplanted into Spinal Cord / ALS Patients
Jan. 04, 2010: Talampanel completes Phase II Trial with 59 ALS Patients
Oct. 5, 2009: NIH Announces Expansion of Rare Diseases Clinical Research Network
Sept. 29. 2009: NIH Office of Extramural Research
Sept. 9, 2009: NINDS Names Petra Kaufmann Director of the Office of Clinical Research
Aug. 6, 2009: Isis Prepares Novel Treatment for Lou Gehrig's Disease...
Aug. 5, 2009: Isis, Genzyme use Antisense to Go Where Many Drugs Fail -- The Brain
Nov. 2006: Growth Factor Stimulates Rapid Extension of Key Motor Neurons in Brain
Summer 2003: ALS Research Consortia Consider Open Label Clinical Trial Design
In Vivo / Blogspot
--------------------------
21 CFR 316.20: Orphan Product Application
|